Global Diagnostic Radiopharmaceuticals and Contrast Media Market By Product Type (Contrast Media, Diagnostic Radiopharmaceuticals), By Contrast Media Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Agents), By Radiopharmaceutical Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals, Others), By Application (Oncology Diagnostics, Cardiology Diagnostics, Neurology Diagnostics, Gastrointestinal Imaging, Others), By Imaging Modality (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), SPECT Imaging, Ultrasound Imaging), By End User (Hospitals, Diagnostic Imaging Centers, Research Institutes), By Distribution Channel (Direct Institutional Sales, Specialty Distributors, Online Procurement & Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Companies — Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026–2035